Except the prolonged half-life, GLP-1 RAs share common mechanisms of action with the endogenous GLP-1: augmentation of hyperglycemia-induced insulin secretion, suppression of glucagon secretion at hyper- or euglycemia, and restoring the function of beta-cells [97–100]. This evidence concerns the gene INS and Hyperglycemia.